Zevra Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
06 Sep 23 | BuyUS$48,764 | Thomas Anderson | Individual | 10,000 | US$4.88 | |
06 Sep 23 | BuyUS$4,959 | R. Clifton | Individual | 1,000 | US$4.96 | |
05 Sep 23 | BuyUS$51,333 | John Bode | Individual | 10,000 | US$5.13 | |
05 Sep 23 | BuyUS$2,565 | Joshua Schafer | Individual | 500 | US$5.13 | |
23 Jun 23 | BuyUS$1,636 | Corey Watton | Individual | 275 | US$5.95 | |
09 Jun 23 | BuyUS$1,794 | Corey Watton | Individual | 325 | US$5.52 | |
30 May 23 | BuyUS$2,042 | Corey Watton | Individual | 400 | US$5.11 | |
19 May 23 | BuyUS$5,416 | Joshua Schafer | Individual | 1,000 | US$5.42 | |
18 May 23 | BuyUS$50,418 | John Bode | Individual | 10,000 | US$5.05 | |
18 May 23 | BuyUS$13,562 | R. Clifton | Individual | 2,740 | US$4.95 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 30,531 | 0.073% |
Hedge Funds | 2,453,405 | 5.86% |
Individual Insiders | 3,279,686 | 7.84% |
Institutions | 10,423,007 | 24.9% |
General Public | 25,663,865 | 61.3% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 21.2%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
3,021,660 | US$13.7m | 0% | no data | |||
2,453,405 | US$11.1m | 6.29% | 1.1% | |||
2,410,289 | US$10.9m | 12.1% | no data | |||
1,645,140 | US$7.4m | 2.02% | no data | |||
729,179 | US$3.3m | 7.38% | no data | |||
683,431 | US$3.1m | 1.34% | 0.01% | |||
636,060 | US$2.9m | 1.25% | no data | |||
540,800 | US$2.4m | 0% | 0.22% | |||
387,427 | US$1.8m | 11.5% | 0.74% | |||
334,777 | US$1.5m | 99.7% | no data | |||
301,066 | US$1.4m | 11.3% | no data | |||
268,000 | US$1.2m | 0% | 0.03% | |||
230,783 | US$1.0m | 13.5% | 0.47% | |||
199,268 | US$900.7k | -1.73% | no data | |||
170,500 | US$770.7k | 28.5% | no data | |||
142,548 | US$644.3k | 0% | no data | |||
141,846 | US$641.2k | 0.31% | 0.08% | |||
129,730 | US$586.4k | 0% | no data | |||
114,862 | US$519.2k | 159% | no data | |||
96,130 | US$434.5k | 0% | no data | |||
95,143 | US$430.0k | 0% | 0.01% | |||
89,000 | US$402.3k | 0% | 0.54% | |||
80,433 | US$363.6k | -0.37% | 0.03% | |||
70,240 | US$317.5k | 0% | 0.01% | |||
69,622 | US$314.7k | 250% | no data |